Adrenal gland- TRIM29 negative adrenocortical adenoma.
Adrenal gland- TRIM29 negative adrenocortical adenoma. 
Adrenal gland- TRIM29 negative pheochromocytoma.
Adrenal gland- TRIM29 negative pheochromocytoma. 
Anal canal- Squamous cell carcinoma with strong TRIM29 immunostaining of tumor cells.
Anal canal- Squamous cell carcinoma with strong TRIM29 immunostaining of tumor cells. 
Breast- TRIM29 negative invasive breast cancer of no special type (NST).
Breast- TRIM29 negative invasive breast cancer of no special type (NST). 
Breast- TRIM29 negative invasive lobular breast cancer.
Breast- TRIM29 negative invasive lobular breast cancer. 
Colon- Colorectal adenocarcinoma with a moderate to strong TRIM29 positivity of tumor cells.
Colon- Colorectal adenocarcinoma with a moderate to strong TRIM29 positivity of tumor cells. 
Esophagus- Adenocarcinoma with strong TRIM29 immunostaining of tumor cells.
Esophagus- Adenocarcinoma with strong TRIM29 immunostaining of tumor cells. 
Esophagus- Squamous cell carcinoma with strong TRIM29 immunostaining of tumor cells.
Esophagus- Squamous cell carcinoma with strong TRIM29 immunostaining of tumor cells. 
Kidney- TRIM29 negative clear cell renal cell carcinoma.
Kidney- TRIM29 negative clear cell renal cell carcinoma. 
Larynx- Squamous cell carcinoma with strong TRIM29 immunostaining of tumor cells.
Larynx- Squamous cell carcinoma with strong TRIM29 immunostaining of tumor cells. 
Liver- TRIM29 negative hepatocellular carcinoma.
Liver- TRIM29 negative hepatocellular carcinoma. 
Lung- Adenocarcinoma with moderate to strong TRIM29 immunostaining of tumor cells.
Lung- Adenocarcinoma with moderate to strong TRIM29 immunostaining of tumor cells. 
Lung- Malignant mesothelioma with strong TRIM29 immunostaining of >50% of tumor cells.
Lung- Malignant mesothelioma with strong TRIM29 immunostaining of >50% of tumor cells. 
Lung- TRIM29 negative adenocarcinoma.
Lung- TRIM29 negative adenocarcinoma. 
Lung- TRIM29 negative small cell carcinoma.
Lung- TRIM29 negative small cell carcinoma. 
Ovary- Brenner tumor with strong TRIM29 immunostaining of epithelial tumor cell nests.
Ovary- Brenner tumor with strong TRIM29 immunostaining of epithelial tumor cell nests. 
Ovary- Endometroid carcinoma with weak to moderate, membranous TRIM29 immunostaining of about 50% of tumor cells.
Ovary- Endometroid carcinoma with weak to moderate, membranous TRIM29 immunostaining of about 50% of tumor cells. 
Ovary- Mucinous carcinoma with weak to moderate TRIM29 immunostaining of the majority of tumor cells.
Ovary- Mucinous carcinoma with weak to moderate TRIM29 immunostaining of the majority of tumor cells. 
Ovary- Serous high-grade carcinoma with a moderate TRIM29 immunostaining of luminal membranes of tumor cells.
Ovary- Serous high-grade carcinoma with a moderate TRIM29 immunostaining of luminal membranes of tumor cells. 
Pancreas- Ductal adenocarcinoma with strong TRIM29 immunostaining of tumor cells.
Pancreas- Ductal adenocarcinoma with strong TRIM29 immunostaining of tumor cells. 
Pancreas- TRIM29 negative acinar cell carcinoma.
Pancreas- TRIM29 negative acinar cell carcinoma. 
Pancreas- TRIM29 negative neuroendocrine tumor.
Pancreas- TRIM29 negative neuroendocrine tumor. 
Penis- Squamous cell carcinoma with strong TRIM29 positivity of tumor cells.
Penis- Squamous cell carcinoma with strong TRIM29 positivity of tumor cells. 
Pharynx- Squamous cell carcinoma with strong TRIM29 immunostaining of tumor cells.
Pharynx- Squamous cell carcinoma with strong TRIM29 immunostaining of tumor cells. 
Prostate- TRIM29 negative adenocarcinoma (Gleason 3+3=6).
Prostate- TRIM29 negative adenocarcinoma (Gleason 3+3=6). 
Salivary gland- Warthin tumor with weak to moderate, membranous TRIM29 immunostaining, mainly of the basal cell layers and of luminal membranes.
Salivary gland- Warthin tumor with weak to moderate, membranous TRIM29 immunostaining, mainly of the basal cell layers and of luminal membranes. 
Skin- Basal cell carcinoma with strong TRIM29 immunostaining of tumor cells.
Skin- Basal cell carcinoma with strong TRIM29 immunostaining of tumor cells. 
Skin- TRIM29 negative malignant melanoma.
Skin- TRIM29 negative malignant melanoma. 
Soft tissue- TRIM29 negative leiomyosarcoma.
Soft tissue- TRIM29 negative leiomyosarcoma. 
Stomach- Adenocarcinoma with moderate membranous TRIM29 positivity of tumor cells.
Stomach- Adenocarcinoma with moderate membranous TRIM29 positivity of tumor cells. 
Stomach- TRIM29 negative gastrointestinal stromal tumor (GIST).
Stomach- TRIM29 negative gastrointestinal stromal tumor (GIST). 
Testis- TRIM29 negative Leydig cell tumor.
Testis- TRIM29 negative Leydig cell tumor. 
Testis- TRIM29 negative seminoma.
Testis- TRIM29 negative seminoma. 
Thyroid- TRIM29 negative medullary carcinoma.
Thyroid- TRIM29 negative medullary carcinoma. 
Thyroid- TRIM29 negative papillary carcinoma.
Thyroid- TRIM29 negative papillary carcinoma. 
Urinary bladder- Muscle-invasive urothelial carcinoma with strong TRIM29 immunostaining of tumor cells.
Urinary bladder- Muscle-invasive urothelial carcinoma with strong TRIM29 immunostaining of tumor cells. 
Urinary bladder- Non-invasive urothelial carcinoma (low grade, pTaG2) with strong TRIM29 immunostaining of tumor cells.
Urinary bladder- Non-invasive urothelial carcinoma (low grade, pTaG2) with strong TRIM29 immunostaining of tumor cells. 
Urinary bladder- Sarkomatoid carcinoma with strong TRIM29 immunostaining of tumor cells.
Urinary bladder- Sarkomatoid carcinoma with strong TRIM29 immunostaining of tumor cells. 
Vulva- Squamous cell carcinoma with strong TRIM29 immunostaining of tumor cells.
Vulva- Squamous cell carcinoma with strong TRIM29 immunostaining of tumor cells.